Development of 225Ac- and 213Bi-labelled somatostatin analogues with improved tumour to kidney ratio for the treatment of neuroendocrine tumours
| University | KU LEUVEN |
|---|---|
| Phd started on | |
| Thesis obtained on |
Mentor
Ooms MaartenPromotor
Bormans GuyCandidate
Ahenkorah StephenBefore applying, please consult the guidelines for application for PhD